ADME Toxicology Testing Market Outlook 2026-2030: North America Leads as Asia-Pacific Emerges as Fastest-Growing Region
核心洞察
A new market outlook covering 2026-2030 projects continued growth in ADME toxicology testing demand, driven by expansion of the global pharmaceutical industry.
North America was the largest regional market in 2025, while Asia-Pacific is expected to be the fastest-growing region through the forecast period.
European pharmaceutical production reached EUR 390.0 billion ($422.8 billion) in 2023, up from EUR 363.3 billion ($393.9 billion) in 2022, according to EFPIA.
Expansion of the pharmaceutical industry is strengthening demand for absorption, distribution, metabolism, excretion (ADME) and toxicology testing services and technologies, according to a new market outlook covering 2026 to 2030. These assessments allow researchers to evaluate the ADME properties and potential toxicity of drug candidates, with the resulting data supporting candidate selection, preclinical development, regulatory submissions, and decisions regarding clinical advancement.
Pharmaceutical Manufacturing Growth Underpins Demand
According to the European Federation of Pharmaceutical Industries and Associations (搜索), total pharmaceutical production in Europe reached €390.0 billion ($422.8 billion) in 2023, compared with €363.3 billion ($393.9 billion) in 2022. Continued pharmaceutical manufacturing growth, combined with sustained investment in drug discovery and development, is expected to increase demand for advanced ADME testing instruments, assays, software, and related services.
Digital Platforms Target Procurement and Data Timelines
Technology providers are responding by introducing digital platforms that simplify access to ADME-Tox services. In October 2023, Germany-based biotechnology company Evotec SE launched the Cyprotex (搜索) e-Store, an e-commerce platform offering online access to its ADME-Tox service portfolio. Registered users can review protocols and pricing, order services, monitor project progress, and place repeat orders. The platform is designed to streamline procurement, shorten lead times, and accelerate the delivery of data needed for drug development programs.
Regional Dynamics
North America was the largest region in the ADME toxicology testing market in 2025, supported by its established pharmaceutical and biotechnology industries, advanced research infrastructure, and strong focus on regulatory compliance. Asia-Pacific is expected to be the fastest-growing region during the forecast period as drug development, contract research, and life sciences investment continue to expand.
The geographic market covered by the outlook includes Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. Countries covered include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, the United Kingdom, the United States, Canada, Italy, and Spain.
Market Segmentation
The outlook segments the ADME toxicology testing market across five dimensions:
- By product type: instruments; software solutions; assay systems; reagents; other product types.
- By method: cellular assay; biochemical assay; in silica; ex-vivo.
- By technology: cell culture; high throughput; molecular imaging; OMICS technology; other technologies.
- By application: systemic toxicity; renal toxicity; hepatotoxicity; neurotoxicity; other applications.
- By end-user: cosmetics and household products; pharmaceutical industry; animal industry; food industry; other end users.
Subsegments include instruments divided into high-throughput screening instruments, LC-MS or MS (liquid chromatography-mass spectrometry), HPLC (high-performance liquid chromatography), and automated workstations. Software solutions are split into data management software, simulation and modeling software, and risk assessment software. Assay systems comprise cell-based assays, in vitro assays, and bioanalytical assays, while reagents include biochemicals, buffer solutions, and culture media. Other products cover kits and consumables and analytical standards.
The report provides a time series of five years historic and ten years forecast, with data covering ratios of market size and growth to related markets, GDP proportions, and expenditure per capita, alongside country and regional historic and forecast data, competitor market share, and market segments.
Companies Featured
Companies featured in the ADME toxicology testing market report include AbbVie Inc., Thermo Fisher Scientific Inc. (搜索), Boehringer Ingelheim GmbH, Laboratory Corporation of America Holdings (搜索), Corning Incorporated (搜索), Eurofins Scientific SE (搜索), Agilent Technologies Inc. (搜索), Lonza Group AG (搜索), Dassault Systemes SE (搜索), Catalent Inc. (搜索), Charles River Laboratories International Inc. (搜索), Beckman Coulter Inc. (搜索), PerkinElmer Inc. (搜索), Bio-Rad Laboratories Inc. (搜索), Curia Global Inc., Promega Corporation (搜索), Takara Bio Inc (搜索)., AB Sciex LLC (搜索), QPS Holdings LLC, Simulations Plus Inc. (搜索), Cyprotex (搜索), XenoTech LLC (搜索), BioIVT LLC (搜索), Absorption Systems, Creative Bioarray (搜索), SOLVO Biotechnology Rt. (搜索), Creative Biolabs Inc (搜索)., Gentronix Limited (搜索), Admecell Inc. (搜索), and Molecular Discovery Ltd. (搜索)